Evaluation of Serum Uric Acid and Creatinine in Post-Menopausal Women Residing in Maiduguri Metropolitan Council (MMC) As a Risk Factor for Renal Failure

Menopause is a turning point in the life of a woman where the woman faces hormonal changes that may predispose the individual to different health problems and renal dysfunction being one of them. This analysis did an assessment on the uric acid and creatinine concentrations in the serum of post-menopausal women living in Maiduguri Metropolitan Council (MMC) as a way of determining whether they can be used as early predictors of the risk of renal failure. A total of 215 volunteers were recruited, of which 165 were post-menopausal women and 50 were pre-menopausal controls of the same age group. Blood samples were taken and blood analyzed by regular enzyme and colorimetric methods. The findings showed that there were significantly higher levels of serum uric acid (427.10 ± 114.54µmol/L) and creatinine (118.43 ± 60.35µmol/L) in post-menopausal women than in the control group (p < 0.05). Further, there was a weak but significant positive correlation between serum uric acid and creatinine (r= 0 53) and each biomarker with the BMI. This is an indication that menopause can be a predisposing factor to kidney impairment because of the loss of protective effects that estrogen had on the kidney. It is recommended that renal biomarkers should be monitored regularly in women, especially post-menopausal and peri-menopausal women to detect the onset of chronic kidney disease and prevent it.

Menopause, Post-menopausal women, chronic kidney disease (CKD), Biomarkers, Body mass index (BMI), Estrogen, uric acid, creatinine.

1. Ameh, N., Madugu, N. H., Onwusulu, D., Eleje, G., &Oyefabi, A. (2016).Prevalence and predictors of menopausal symptoms among postmenopausal Ibo and Hausa women in Nigeria.Tropical Journal of Obstetrics and Gynaecology, 33(3), 263. [Google Scholar] [Crossref]

2. Braga, T. T., Foresto-Neto, O., &Camara, N. O. S. (2020).The role of uric acid in inflammasome-mediated kidney injury.Current Opinion in Nephrology and Hypertension, 29(4), 423-431. [Google Scholar] [Crossref]

3. Brinton, RD., Yao, J., Yin, F., Mack, WJ.,Cadenas, E., (2015). Perimenopause as a neurological transition state, Nat Rev Endocrinol. 11 (7), 393-405. [Google Scholar] [Crossref]

4. Brosnan, J. T., &Brosnan, M. E. (2010).Creatine metabolism and the urea cycle.Molecular genetics and metabolism, 100, S49-S52. [Google Scholar] [Crossref]

5. Castelo-Branco, C, Cancelo, M. J., Villero, J, Nohales, F., & Julia, M. D. (2015) Management of post-menopausal vaginal atrophy and atrophic vaginitis.Maturitas, 52, 46-52. [Google Scholar] [Crossref]

6. Chaudhary, K., Malhotra, K., Sowers, J., &Aroor, A. (2013).Uric acid-key ingredient in the recipe for cardiorenal metabolic syndrome.Cardiorenal medicine, 3(3), 208-220. [Google Scholar] [Crossref]

7. Cho, S. K., Winkler, C. A., Lee, S. J., Chang, Y., &Ryu, S. (2019). The prevalence of hyperuricemia sharply increases from the late menopausal transition stage in middle-aged women. Journal of clinical medicine, 8(3), 296. [Google Scholar] [Crossref]

8. Col, N. F., Guthrie, J. R., Politi, M., &Dennerstein, L. (2016). Duration of vasomotor symptoms in middle-aged women: a longitudinal study. Menopause, 16(3), 453-457. [Google Scholar] [Crossref]

9. Dalal, P. K., & Agarwal, M. (2015).Postmenopausal syndrome. Indian journal of psychiatry, 57(Suppl 2), S222-S232. [Google Scholar] [Crossref]

10. Edmund J. L, and Christopher P.P. (2015). Kidney function test-creatinine, urea anduric acid.In; Carl B.A and David B. E. Tietz fundamentals of clinical chemistry and molecular diagnostics. 7th edt; 364-370. [Google Scholar] [Crossref]

11. Frassetto, L, Morris Jr, R. C., & Sebastian, A. (2005). Potassium bicarbonate reduces urinary nitrogen excretion in postmenopausal women. The Journal of Clinical Endocrinology & Metabolism, 82(1), 254-259 [Google Scholar] [Crossref]

12. Freedman, M. (2018).Vaginal pH, estrogen and genital atrophy.Menopause Management, 17(4), 9-13. [Google Scholar] [Crossref]

13. Freeman, E W, Sammel, M. D, & Sanders, RJ (2014) Risk of long term hot flashes after natural menopause evidence from the Penn Ovarian Aging Cohort. Menopause (New York, NY). 21(9), 924 [Google Scholar] [Crossref]

14. Hak, A. E., Curhan, G. C., Grodstein, F., & Choi, H. K. (2010).Menopause, postmenopausal hormone use and risk of incident gout.Annals of the rheumatic diseases, 69(7), 1305-1309. [Google Scholar] [Crossref]

15. Harlow, SD., Gass, M., Hall, JE., Lobo, R., Maki, P., Rebar, RW., Sherman, S., Sluss, PM, de-Villiers, TJ., (2012). Executive summary of the stages of reproductive aging workshop+ 10: addressing the unfinished agenda of staging reproductive aging. Menopause.19 (4), 387-95. [Google Scholar] [Crossref]

16. Harlow, SD., Gass, M., Hall, JE., Lobo, R., Maki, P., Rebar, RW., Sherman, S., Sluss, PM, de-Villiers, TJ., (2012). Executive summary of the stages of reproductive aging workshop+ 10: addressing the unfinished agenda of staging reproductive aging. Menopause.19 (4), 387-95. [Google Scholar] [Crossref]

17. Hoffman, Barbara (2012). Williams gynecology. New York: McGraw-Hill Medical. pp. 555–56. [Google Scholar] [Crossref]

18. Ikegwuonu, I. C., Okwor, C. P., Chukwu, J. I., & Mba, B. C. (2020). Assessment of serum Calcium, Alkaline phosphatase and Creatinine levels in postmenopausal women in Enugu metropolis. [Google Scholar] [Crossref]

19. Jaromir K., Radim C. (2008). Clinic schemistry and enzymology laboratory manual. [Google Scholar] [Crossref]

20. Johnson, R. J. Bakris, G. L, Borghi, C., Chonchol, M. B Feldman, D, Lanaspa, M A, &Chertow, G. M. (2018) Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease report of a scientific workshop organized by the National Kidney Foundation. American Journal of Kidney Diseases, 71(6), 851 865. [Google Scholar] [Crossref]

21. Jurimae, J., & Jurimae, T. (2007). Plasma adiponectin concentration in healthy pre-and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. American Journal of Physiology-Endocrinology and Metabolism, 293(1), E42-E47. [Google Scholar] [Crossref]

22. Kravitz, H. M., Zheng, H., Bromberger, J. T., Buysse, D. J., Owens, J., & Hall, M. H. (2015).An Actigraphy Study of Sleep and Pain in Midlife Women–The SWAN Sleep Study.Menopause (New York, NY), 22(7), 710. [Google Scholar] [Crossref]

23. Lesley A. I, Andrew S L (2019). Measurement and estimation of kidney function; in Jonathan H., Alplkizler T. Chronic kidney disease, dialysis and transportation. 4th edt; 23-41. [Google Scholar] [Crossref]

24. Lizcano, F, & Guzman, G. (2014). Estrogen deficiency and the origin of obesity during menopause.BioMed research international, 2014. [Google Scholar] [Crossref]

25. MacLean R.A, Ndubuisi N.U (2017), Asymptomatic chronic kidney disease and correlations in untreated hypertensive patients attending a referral hospital in southern Nigeria, clinical practice,6(1) 9-14. [Google Scholar] [Crossref]

26. Mallat, S. G., Al Kattar, S., Tanios, B. Y., &Jurjus, A. (2016). Hyperuricemia, hypertension, and chronic kidney disease: an emerging association. Current hypertension reports,18(10), 1-6. [Google Scholar] [Crossref]

27. Manber, R., & Armitage, R. (2018). Sex, steroids, and sleep: a review. Sleep, 22(5), 540-541. [Google Scholar] [Crossref]

28. Marangella, M. (2005).Uric acid elimination in the urine.Hyperuricemic syndromes: pathophysiology and therapy, 147, 132-148. [Google Scholar] [Crossref]

29. Matsuo, H., Takada, T, Nakayama, A, Shimizu, T., Sakiyama, M., Shimizu, S., & Ichida, K (2014) ABCG2 dysfunction increases the risk of renal overload hyperuricemia. Nucleosides, Nucleotides and Nucleic Acids, 33(4-6), 266-274 [Google Scholar] [Crossref]

30. Messinis, I. E, Messini, C. I., Anifandis, G., &Dafopoulos, K. (2015) Polycystic ovaries and obesity. Best Practice & Research Clinical Obstetrics &Gynaecology, 29(4), 479-488. [Google Scholar] [Crossref]

31. Mishra, G D., &Kuh, D. (2012) Health symptoms during midlife in relation to menopausal transition: British prospective cohort study Bmj, 344. [Google Scholar] [Crossref]

32. Monterrosa-Castro, A., Romero-Pérez, I., Marrugo-Flórez, M., Fernández-Alonso, A.M., Chedraui, P. and Pérez-López, F.R., 2012. Quality of life in a large cohort of mid-aged Colombian women assessed using the Cervantes Scale. Menopause, 19(8), pp.924-930. [Google Scholar] [Crossref]

33. Mumford, S. L., Dasharathy, S. S, Pollack, A. Z., Perkins, N. J., Mattison, D. R, Cole, S. R. &Schisterman, E. F. (2013) Serum uric acid in relation to endogenous reproductive hormones during the menstrual cycle findings from the BioCycle study. Human reproduction, 28(7), 1853-1862. [Google Scholar] [Crossref]

34. Nafada, B.G., Baba, M.M., Hyelcinta C.J., Tahir, B., Talle, M., Obi, S.O. (2011).Capacity Utilization of University of Maiduguri Teaching Hospital, Nigeria.Report and Opinion3(8):35-38. [Google Scholar] [Crossref]

35. Ohayon, M. M. (2016). Severe hot flashes are associated with chronic insomnia. Archives of internal medicine, 166(12), 1262-1268. [Google Scholar] [Crossref]

36. Park, J. I., Baek, H., & Jung, H. H. (2016). Prevalence of chronic kidney disease in korea: The korean national health and nutritional examination survey 2011–2013. Journal of Korean medical science, 31(6), 915-923. [Google Scholar] [Crossref]

37. Park, Y. J., & Kim, J. M. (2018).Klotho and postmenopausal hormone replacement therapy in women with chronic kidney disease.Journal of menopausal medicine, 24(2), 75-80. [Google Scholar] [Crossref]

38. Pérez-López, F. R., Cuadros, J. L., Fernández-Alonso, A. M., Chedraui, P., Sánchez-Borrego, R., &Monterrosa-Castro, A. (2012).Urinary incontinence, related factors and menopause-related quality of life in mid-agedwomenassessed with the Cervantes Scale.Maturitas, 73(4), 369-372.l [Google Scholar] [Crossref]

39. Prince, C. T., Secrest, A. M., Mackey, R. H., Arena, V. C., Kingsley, L. A., & Orchard, T. J. (2010). Augmentation pressure and subendocardial viability ratio are associated with microalbuminuria and with poor renal function in type 1 diabetes. Diabetes and Vascular Disease Research, 7(3), 216-224. [Google Scholar] [Crossref]

40. Ramesh, S., James, M. T., Holroyd-Leduc, J. M., Wilton, S. B., Seely, E. W., Wheeler, D. C., & Ahmed, S. B. (2017). Sex hormone status in women with chronic kidney disease: survey of nephrologists’ and renal allied health care providers’ perceptions. Canadian Journal of Kidney Health and Disease, 4. [Google Scholar] [Crossref]

41. Ruilope, L. M., & Garcia-Puig, J. (2016).Hyperuricemia and renal function.Current hypertension reports, 3(3), 197-202. [Google Scholar] [Crossref]

42. Salazar, J. H (2014) Overview of urea and creatinine. Laboratory medicine, 45(1), e19-20. [Google Scholar] [Crossref]

43. Santoro, N., Epperson, C. N., & Mathews, S. B. (2015).Menopausal symptoms and their management.Endocrinology and Metabolism Clinics, 44(3), 497-515. [Google Scholar] [Crossref]

44. Schaubel, D. E., Jeffery, J. R., Mao, Y., Semenciw, R., Yeates, K., & Fenton, S. S. (2002). Trends in mortality and graft failure for renal transplant patients.Cmaj, 167(2), 137-142. [Google Scholar] [Crossref]

45. Sherman, S., Miller, H., Nerurkar, L., & Schiff, I. (2017).Research opportunities for reducing the burden of menopause-related symptoms.The American journal of medicine, 118(12), 166-171. [Google Scholar] [Crossref]

46. Sievert, Lynnette Leidy. "Evolutionary perspectives, comparative approaches, and the lived experience of menopause." American journal of biological anthropology 186 (2024): e25067. [Google Scholar] [Crossref]

47. Soares, C. N. (2023). Anxiety and depression in midlife transition and beyond: the role of estrogens. Current Opinion in Endocrine and Metabolic Research, 31, 100457. [Google Scholar] [Crossref]

48. Soares, C. N., & Warren, M. P. (Eds.). (2009). The menopausal transition: interface between gynecology and psychiatry (Vol. 175). Karger Medical and Scientific Publishers. [Google Scholar] [Crossref]

49. Takahashi TA, Johnson KM (2015). Menopause,The Medical Clinics of North America. 99 (3): 521–34. [Google Scholar] [Crossref]

50. Thurston, RC, Chang, Y Barinas-Mitchell, E Jennings, J. R. von Känel, R, Landsittel, D. P & Matthews, K A (2017) Physiologically assessed hot flashes and endothelial function among midlife women. Menopause (New York, NY), 24(8), 886. [Google Scholar] [Crossref]

51. Utian, W. H (2014) Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health and Quality of Life outcomes, 3(1), 1-10. [Google Scholar] [Crossref]

52. Wurz, G. T. Kao C J,&DeGregorio, M W (2014) Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause. Clinical Interventions in Aging, 9, 1939. [Google Scholar] [Crossref]

53. Yu, M., Ryu, D. R., Kim, S. J., Choi, K. B., & Kang, D. H. (2010). Clinical implication of metabolic syndrome on chronic kidney disease depends on gender and menopausal status: results from the Korean National Health and Nutrition Examination Survey. Nephrology Dialysis Transplantation, 25(2), 469-477. [Google Scholar] [Crossref]

• Measuring Waste of Patient Time in Health Care at Non-Digitized Hospital: An Observational Study in Bangabandhu Sheikh Mujib Medical University, Bangladesh
• Reaffirming Clinical Confidence in Atorvastatin Therapy: A Digital Outreach Case Study from Tamil Nadu, India
• Clinical Manifestations and Therapeutic Response in a Patient with Hypothyroidism: A Case Report
• Eranda (Ricinus Communis) In Gridhrasi (Sciatica): Classical Rationale, Pharmacology and Clinical Evidence- A Narrative Literature Review
• Magnetotherapy in Pain Management: Mechanisms, Clinical Applications, and Future Perspectives – A Review